Shay Capital LLC Novo Nordisk A S Transaction History

Shay Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$119.07 - $145.42 $1.58 Million - $1.93 Million	-13,278 Reduced 78.51%	3,634 $432,000
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $357,331 - $427,801	2,912 Added 20.8%	16,912 $2.41 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $918,990 - $1.22 Million	9,000 Added 180.0%	14,000 $1.8 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $438,900 - $527,250	5,000 New	5,000 $517,000
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $359,070 - $438,464	-3,745 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $316,152 - $399,291	3,745 New	3,745 $360,000
Q2 2021 Aug 13, 2021	SELL	$67.66 - $84.76 $202,980 - $254,280	-3,000 Closed	0 $0
Q1 2021 Aug 13, 2021	BUY	$67.06 - $75.82 $201,180 - $227,459	3,000 New	3,000 $202,000

1,874

336M

11.9M

10.7M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $176B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.